KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teladoc Health (TDOC) Cash from Operations (2016 - 2025)

Historic Cash from Operations for Teladoc Health (TDOC) over the last 12 years, with Q3 2025 value amounting to $99.3 million.

  • Teladoc Health's Cash from Operations fell 990.33% to $99.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $292.5 million, marking a year-over-year decrease of 1342.06%. This contributed to the annual value of $293.7 million for FY2024, which is 1609.65% down from last year.
  • According to the latest figures from Q3 2025, Teladoc Health's Cash from Operations is $99.3 million, which was down 990.33% from $91.4 million recorded in Q2 2025.
  • Teladoc Health's 5-year Cash from Operations high stood at $130.1 million for Q4 2023, and its period low was -$31.7 million during Q1 2022.
  • For the 5-year period, Teladoc Health's Cash from Operations averaged around $64.9 million, with its median value being $83.2 million (2021).
  • Within the past 5 years, the most significant YoY rise in Teladoc Health's Cash from Operations was 17239.51% (2021), while the steepest drop was 18522.15% (2021).
  • Quarter analysis of 5 years shows Teladoc Health's Cash from Operations stood at $83.2 million in 2021, then dropped by 21.22% to $65.5 million in 2022, then soared by 98.45% to $130.1 million in 2023, then crashed by 33.96% to $85.9 million in 2024, then rose by 15.55% to $99.3 million in 2025.
  • Its Cash from Operations stands at $99.3 million for Q3 2025, versus $91.4 million for Q2 2025 and $15.9 million for Q1 2025.